Transcribed
The History and Future of Oligonucleotide Drug Development
Jul 5, 2023 ·
38m 31s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
The History and Future of Oligonucleotide Drug Development
This is an automatically generated transcript. Please note that complete accuracy is not guaranteed.
Description
In this new ACT ToxChats© episode, Dr. Jeffrey Foy, Vice President of Toxicology at Pepgen and Dr. Scott Henry, Vice President of Nonclinical Development at Ionis Pharmaceuticals are interviewed. Drs....
show more
In this new ACT ToxChats© episode, Dr. Jeffrey Foy, Vice President of Toxicology at Pepgen and Dr. Scott Henry, Vice President of Nonclinical Development at Ionis Pharmaceuticals are interviewed. Drs. Foy and Henry discuss the past, present, and future of oligonucleotides. Their focus is discussing the development and challenges that oligonucleotides face as a class of drugs.
show less
Information
| Author | ACT ToxChats |
| Organization | ACT ToxChats |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
